Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome

Patients who later have a mild course of hantavirus cardiopulmonary syndrome (HCPS) are more likely to exhibit a high titer of neutralizing antibodies against Sin Nombre virus (SNV), the etiologic agent of HCPS, at the time of hospital admission. Because administering plasma from patients who have r...

Full description

Bibliographic Details
Main Authors: Chunyan Ye, Joseph B. Prescott, Robert A. Nofchissey, Diane Goade, Brian Hjelle
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2004-03-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/10/3/02-0821_article
_version_ 1818326065339170816
author Chunyan Ye
Joseph B. Prescott
Robert A. Nofchissey
Diane Goade
Brian Hjelle
author_facet Chunyan Ye
Joseph B. Prescott
Robert A. Nofchissey
Diane Goade
Brian Hjelle
author_sort Chunyan Ye
collection DOAJ
description Patients who later have a mild course of hantavirus cardiopulmonary syndrome (HCPS) are more likely to exhibit a high titer of neutralizing antibodies against Sin Nombre virus (SNV), the etiologic agent of HCPS, at the time of hospital admission. Because administering plasma from patients who have recovered from HCPS to those in the early stages of disease may be an advantageous form of passive immunotherapy, we examined the neutralizing antibody titers of 21 patients who had recovered from SNV infection. Even 1,000 days after admission to the hospital, 6 of 10 patients had titers of 800 or higher, with one sample retaining a titer of 3,200 after more than 1,400 days. None of the convalescent-phase serum samples contained detectable viral RNA. These results confirm that patients retain high titers of neutralizing antibodies long after recovery from SNV infection.
first_indexed 2024-12-13T11:54:27Z
format Article
id doaj.art-29cb9e790ef64c6e963260acf8cfca76
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-13T11:54:27Z
publishDate 2004-03-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-29cb9e790ef64c6e963260acf8cfca762022-12-21T23:47:16ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592004-03-0110347848210.3201/eid1003.020821Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary SyndromeChunyan YeJoseph B. PrescottRobert A. NofchisseyDiane GoadeBrian HjellePatients who later have a mild course of hantavirus cardiopulmonary syndrome (HCPS) are more likely to exhibit a high titer of neutralizing antibodies against Sin Nombre virus (SNV), the etiologic agent of HCPS, at the time of hospital admission. Because administering plasma from patients who have recovered from HCPS to those in the early stages of disease may be an advantageous form of passive immunotherapy, we examined the neutralizing antibody titers of 21 patients who had recovered from SNV infection. Even 1,000 days after admission to the hospital, 6 of 10 patients had titers of 800 or higher, with one sample retaining a titer of 3,200 after more than 1,400 days. None of the convalescent-phase serum samples contained detectable viral RNA. These results confirm that patients retain high titers of neutralizing antibodies long after recovery from SNV infection.https://wwwnc.cdc.gov/eid/article/10/3/02-0821_articlehantavirusSin Nombre virushantavirus cardiopulmonary syndromepersistenceHCPSneutralizing antibody
spellingShingle Chunyan Ye
Joseph B. Prescott
Robert A. Nofchissey
Diane Goade
Brian Hjelle
Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome
Emerging Infectious Diseases
hantavirus
Sin Nombre virus
hantavirus cardiopulmonary syndrome
persistence
HCPS
neutralizing antibody
title Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome
title_full Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome
title_fullStr Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome
title_full_unstemmed Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome
title_short Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome
title_sort neutralizing antibodies and sin nombre virus rna after recovery from hantavirus cardiopulmonary syndrome
topic hantavirus
Sin Nombre virus
hantavirus cardiopulmonary syndrome
persistence
HCPS
neutralizing antibody
url https://wwwnc.cdc.gov/eid/article/10/3/02-0821_article
work_keys_str_mv AT chunyanye neutralizingantibodiesandsinnombrevirusrnaafterrecoveryfromhantaviruscardiopulmonarysyndrome
AT josephbprescott neutralizingantibodiesandsinnombrevirusrnaafterrecoveryfromhantaviruscardiopulmonarysyndrome
AT robertanofchissey neutralizingantibodiesandsinnombrevirusrnaafterrecoveryfromhantaviruscardiopulmonarysyndrome
AT dianegoade neutralizingantibodiesandsinnombrevirusrnaafterrecoveryfromhantaviruscardiopulmonarysyndrome
AT brianhjelle neutralizingantibodiesandsinnombrevirusrnaafterrecoveryfromhantaviruscardiopulmonarysyndrome